Global Non-Clinical CRO Services Market Growth (Status and Outlook) 2024-2030
The global Non-Clinical CRO Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Non-Clinical CRO Services Industry Forecast” looks at past sales and reviews total world Non-Clinical CRO Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Clinical CRO Services sales for 2023 through 2029. With Non-Clinical CRO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Clinical CRO Services industry.
This Insight Report provides a comprehensive analysis of the global Non-Clinical CRO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Clinical CRO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Clinical CRO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Clinical CRO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Clinical CRO Services.
United States market for Non-Clinical CRO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Non-Clinical CRO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Non-Clinical CRO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Non-Clinical CRO Services players cover CMIC Group, Shanghai Innostar Biotech, ApconiX, Charles River Laboratories, ERBC Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Clinical CRO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Safety Pharmacology Testing
Administration Toxicity Test
Reproductive Toxicity Test
Genotoxicity Test
Immunogenicity Studies
Carcinogenicity Test
Other
Segmentation by Application:
Pharmaceutical Center
Institute
Hospital
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Safety Pharmacology Testing
Administration Toxicity Test
Reproductive Toxicity Test
Genotoxicity Test
Immunogenicity Studies
Carcinogenicity Test
Other
Segmentation by Application:
Pharmaceutical Center
Institute
Hospital
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CMIC Group
Shanghai Innostar Biotech
ApconiX
Charles River Laboratories
ERBC Group
STILLMEADOW
ICON
Please note: The report will take approximately 2 business days to prepare and deliver.